Clinical Review Testing patients to allow tailored drug treatment BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7487.352 (Published 10 February 2005) Cite this as: BMJ 2005;330:352 Article Related content Metrics Responses Peer review Related articles Clinical Review Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase Published: 10 February 2005; BMJ 330 doi:10.1136/bmj.330.7487.350 Clinical Review Criteria influencing the clinical uptake of pharmacogenomic strategies Published: 17 June 2004; BMJ 328 doi:10.1136/bmj.328.7454.1482 See more Cochrane launches new research field to tackle overdiagnosis and medical excess BMJ December 07, 2019, 367 l6817; DOI: https://doi.org/10.1136/bmj.l6817 New government is urged not to stoke “unrealistic expectations” about NHS performance BMJ December 06, 2019, 367 l6887; DOI: https://doi.org/10.1136/bmj.l6887 Sixty seconds on . . . mobile phone injuries BMJ December 06, 2019, 367 l6886; DOI: https://doi.org/10.1136/bmj.l6886 One size does not fit all: implementation of interventions for non-communicable diseases BMJ December 06, 2019, 367 l6434; DOI: https://doi.org/10.1136/bmj.l6434 Prioritising action on alcohol for health and development BMJ December 06, 2019, 367 l6162; DOI: https://doi.org/10.1136/bmj.l6162
